Brinzolamide-Loaded Nanoemulsions: In vitro Release Evaluation
Iranian Journal of Pharmaceutical Sciences,
卷 12 编号 3 (2016),
1 July 2016
,
第 75-93 页
https://doi.org/10.22037/ijps.v12.40771
摘要
The aim of this investigation was to design and develop nanoemulsions (NEs) as novel ophthalmic delivery systems for brinzolamide (BZD). Phase behavior of quaternary systems composed of triacetin and CapryolTM 90 (selected oils, screened through the solubility studies), various surfactants (namely, Cremophor RH 40, Brij 35, Labrasol and tyloxapol), Transcutol P (as co-surfactant) and water at different surfactant/co-surfactant weight ratios (Rsm) was investigated by the construction of phase diagrams. Formulations were taken from the o/w NE region on the phase diagrams, depending on the extent of NE domain. The spontaneous emulsification method was used to prepare various formulations containing 0.4 wt% of the drug. The nanosized character of NEs was evaluated, the cumulative drug release from of the selected formulations was determined for a period of 6 h, using a dialysis sac technique and the release efficiency for NEs was calculated. The therapeutic efficacy of the selected BZD-loaded NEs to lower the IOP was assessed by the calculation of various pharmacodynamic parameters (ie., Emax, Tmax AUC0-6h). In all cases, the average size of the droplets was found to be less than 40 nm. In vitro release studies indicated that the release efficiency in most of the NEs was higher as compared to the BZD ophthalmic suspension. Comparison of the pharmacodynamics parameters confirmed the equivalent efficacy of most BZD formulations.
- Nanoemulsion
- Phase diagram
- Brinzolamide
- Ophthalmic delivery
- Biological studies
- Release efficiency
##submission.howToCite##
参考
[2] Gutiérrez JM, González C, Maestro A, Solè I, Pey CM, Nolla J. Nano-emulsions: New applications and optimization of their preparation. Curr. Opin. Colloid Interface Sci. (2008) 13: 245-251.
[3] Solans C, Izquierdo P, Nolla J, Azemar N, Garcia-Celma MJ. Nano-emulsions. Curr. Opin. Colloid Interface Sci. (2005) 10: 102-110.
[4] Chen H, Khemtong C, Yang X, Chang X, Gao J. Nanonization strategies for poorly water-soluble drugs. Drug Discov. Today. (2011) 16: 354-60.
[5] Wang L, Mutch KJ, Eastoe J, Heenan RK, Dong J. Nanoemulsions prepared by a two-step low-energy process. Langmuir. (2008) 24:6092-9.
[6] Sutradhar KB, Amin ML. Nanoemulsions: increasing possibilities in drug delivery. Eur. J. Nanomed. (2013) 5: 97–110.
[7] El-Aasser MS, Lack CD, Vanderhoff JW, Fowkes FM. The miniemulsification process- different form of spontaneous emulsification. Colloids Surf. (1988) 29: 103- 118.
[8] Constantinides PP, Chaubal MV, Shorr R. Advances in lipid nanodispersions for parenteral drug delivery and targeting. Adv. Drug Deliv. Rev. (2008) 60: 757-767.
[9] Tadros T, Izquierdo P, Esquena J, Solans C. Formation and stability of nano-emulsions. Adv. Colloid Interface Sci. (2004) 108-109: 303-318.
[10] Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur. J. Pharm. Biopharm. (2007) 66: 227-243.
[11] Vandamme TF. Microemulsions as ocular drug delivery systems: recent developments and future challenges. Prog. Retin. Eye Res. (2002) 21: 15-34.
[12] Lu Y, Qi J, Wu W. Absorption, disposition and pharmacokinetics of nanoemulsions. Curr. Drug Metabol. (2012): 13: 396-417.
[13] Bali V, Ali M, Ali J. Study of surfactant combinations and development of a novel nanoemulsion for minimizing variations in bioavailability of ezetimibe. Colloids Surf. B. Biointerfaces. (2010) 76: 410-420.
[14] Morsi M, Mohamad MI, Refal H, El Sorogy HM. Nanoemulsion as a novel ophthalmic delivery system for acetazolamide. Int. J. Pharm. Pharm. Sci. (2014) 6:227-36.
[15] Ammar HO, Salama HA, Ghorab M, Mahmoud AA. Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride. AAPS Pharm SciTech. (2009) 10: 808-19.
[16] Ghai D, Sinha VR. Nanoemulsions as self- emulsified drug delivery carriers for enhanced permeability of the poorly water soluble selective 1-adrenoreceptor blocker talinolol. Nanomed.: Nanotechnol. Biol. Med. (2012) 8: 618-626.
[17] Heloise R, Crauste- Manciet S, Seguin J, Brossard D, Scherman D, Arnaud PH, Ghabot GG. Nanoemulsion formulation of fisetin improves bioavailability and anti-tumor activity in mice. Int. J. Pharm. (2012) 427: 452-459.
[18] Araújo FA, Kelmann RG, Araújo BV, Finatto RB, Teixeira HF, Koester LS. Developing and characterization of parenteral nanoemulsion containing thalidomide. Euro. J. Pharm. Sci. (2011) 42: 238-245.
[19] Tuomela A, Liu P, Puranen J, Rönkkö S, Laaksonen T, Kalesnykas G, Oksala O, Ilka J, Laru J, Järvinen K4, Hirvonen J, Peltonen L. Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo. Int. J. Pharm. (2014) 5:467(1-2):34-41.
[20] Khan KA, Rhodes CT. Effect of compaction pressure on the dissolution efficiency of some direct compression systems. Pharm. Acta Helv. (1972) 47:594-607.
[21] Azeem A, Rizwan M, Ahmad FJ, Iqbal Z, Khar RK, Aqil M, Talegaonkar S. Nanoemulsion components screening and selection: a technical note. AAPS PharmSciTech. (2009)10:69-76.
[22] Shafiq-un-Nabi S, Shakeel F, Talegaonkar S, Ali J, Baboota S, Ahuja A, Khar RK and Ali M. Formulation development and optimization using nanoemulsion technique: a technical note. AAPS PharmSciTech. (2007) 8: E12-E17.
[23] Lawrence MJ and Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. (2000) 45:89-121.
[24] Gursoy RN and Benita S. Self-emulsifying drug delivery systems for improved oral delivery of lipophilic drugs. Biomed Pharmacother. (2004) 58:173-182.
[25] Kawakami K, Yoshikawa T, Moroto Y, Kanaoka E, Takahashi K, Nishihara Y and Masuda K. Microemulsion formulation for enhanced absorption of poorly soluble drugs. II. In vivo study. J Control Rel. (2002) 81:75–82.
[26] Warisnoicharoen W, Lansley AB and Lawrence MJ. Light scattering investigations on dilute non-ionic oil-in-water microemulsions. AAPS PharmSci. (2000) 2: E12.
[27] Kesavan K, Pandit JK, Kant S, Muthu MS. Positively charged microemulsions of dexamethasone: comparative effects of two cosurfactants on ocular drug delivery and bioavailability. Ther. Deliv. (2013) 4:1385-95.
- 摘要 ##plugins.themes.ojsPlusA.frontend.article.viewed##: 95 ##plugins.themes.ojsPlusA.frontend.article.times##
- IJPS_Volume 12_Issue 3_Pages 75-93 (English) ##plugins.themes.ojsPlusA.frontend.article.downloaded##: 30 ##plugins.themes.ojsPlusA.frontend.article.times##